Table 2 Patient- and lesion-based analysis of SSTR-PET and CT
From: Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
Metastatic sites | A) Patient-based assessment | B) Lesion-based assessment | ||||
|---|---|---|---|---|---|---|
SSTR-PET | CT | SSTR-PET sensitivity/specificity/accuracy | SSTR-PET | CT | SSTR-PET sensitivity | |
Lymph node | 8 | 11 | 73%/ 92%/ 83% | 62 | 105 | 59% |
Lung | 0 | 2 | 0%/ 100%/ 95% | 0 | 6 | 0% |
Pleura | 1 | 2 | 50%/ 100%/ 95% | 1 | 2 | 50% |
Pancreas | 1 | 1 | n/a | 1 | 1 | n/a |
Bone | 5 | 2 | 100%/ 83%/ 85% | 35 | 20 | 100% |
Soft tissue | 5 | 3 | 67%/ 90%/ 86% | 8 | 2 | 100% |
Liver | 0 | 5 | 0%/ 100%/ 80% | 0 | 33 | 0% |